Littlejohn & Co. LLC reduced its position in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Free Report) by 8.9% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 8,113,120 shares of the company’s stock after selling 789,678 shares during the period. Aveanna Healthcare accounts for approximately 21.4% of Littlejohn & Co. LLC’s portfolio, making the stock its 2nd largest holding. Littlejohn & Co. LLC’s holdings in Aveanna Healthcare were worth $42,188,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Creative Planning raised its position in shares of Aveanna Healthcare by 21.3% in the third quarter. Creative Planning now owns 48,502 shares of the company’s stock valued at $252,000 after purchasing an additional 8,502 shares during the period. Bank of New York Mellon Corp grew its stake in Aveanna Healthcare by 6.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 149,761 shares of the company’s stock valued at $413,000 after buying an additional 9,243 shares in the last quarter. Mackenzie Financial Corp raised its holdings in Aveanna Healthcare by 35.9% during the 2nd quarter. Mackenzie Financial Corp now owns 45,674 shares of the company’s stock valued at $126,000 after acquiring an additional 12,075 shares during the period. Intech Investment Management LLC purchased a new stake in shares of Aveanna Healthcare during the third quarter worth $69,000. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of Aveanna Healthcare by 3.9% in the third quarter. Charles Schwab Investment Management Inc. now owns 462,659 shares of the company’s stock worth $2,406,000 after acquiring an additional 17,522 shares during the period. Institutional investors own 87.96% of the company’s stock.
Aveanna Healthcare Trading Up 0.7 %
Shares of AVAH stock opened at $5.84 on Monday. Aveanna Healthcare Holdings Inc. has a 52-week low of $2.00 and a 52-week high of $6.19. The business’s fifty day moving average is $5.20 and its 200 day moving average is $4.19.
Wall Street Analyst Weigh In
A number of analysts recently issued reports on the company. Royal Bank of Canada boosted their price objective on Aveanna Healthcare from $3.00 to $5.00 and gave the company a “sector perform” rating in a research note on Friday, August 9th. UBS Group increased their price target on shares of Aveanna Healthcare from $1.70 to $2.80 and gave the stock a “sell” rating in a report on Friday, August 9th. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Aveanna Healthcare from $3.00 to $5.00 and gave the company a “buy” rating in a research note on Friday, August 9th.
View Our Latest Report on AVAH
Aveanna Healthcare Profile
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Read More
- Five stocks we like better than Aveanna Healthcare
- EV Stocks and How to Profit from Them
- 3 Forces Shaping a Bullish 2025 Outlook
- Why is the Ex-Dividend Date Significant to Investors?
- Should Investors Chase Tech Gains Into Year-End?
- How to Use the MarketBeat Stock Screener
- 2 Solar Stocks to Watch as Election Sparks Uncertainty
Want to see what other hedge funds are holding AVAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Free Report).
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.